neffy, epinephrine nasal spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at-Risk of Anaphylaxis: Phase 3 Study Results

被引:0
|
作者
Ebisawa, Motohiro [1 ]
Lowenthal, Richard [2 ]
Tanimoto, Sarina [3 ]
Takahashi, Kento [4 ]
Takahashi, Kyohei Kyohei [4 ]
Yanagida, Noriyuki [4 ]
Sato, Sakura [4 ]
机构
[1] Sagamihara Natl Hosp, Sagamihara, Japan
[2] ARS Pharmaceut, San Diego, CA USA
[3] ARS Pharmaceut Inc, San Diego, CA USA
[4] NHO Sagamihara Natl Hosp, Sagamihara, Japan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
L33
引用
收藏
页码:AB371 / AB371
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of erenumab in episodic migraine patients with 2-4 prior preventive treatment failures: Results from the Phase 3b LIBERTY study
    Reuter, Uwe
    Goadsby, Peter J.
    Lanteri-Minet, Michel
    Ferrari, Michel
    Wen, Shihua
    Klatt, Jan
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [42] Bimekizumab Long-Term Safety and Efficacy in Patients with Ankylosing Spondylitis: Interim Results After 3 Years of Treatment in an Ongoing Phase 2b Study
    Gensler, Lianne
    Deodhar, Atul
    van der Heijde, Desiree
    Poddubnyy, Denis
    Kivitz, Alan
    Dougados, Maxime
    de Peyrecave, Natasha
    Oortgiesen, Marga
    Vaux, Thomas
    Fleurinck, Carmen
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1015 - 1019
  • [43] Efficacy and Safety of Erenumab in Episodic Migraine Patients with 2-4 Prior Preventive Treatment Failures: Results from the Phase 3b LIBERTY Study
    Goadsby, P. J.
    Lanteri-Minet, M.
    Ferrari, M.
    Wen, S.
    Klatt, J.
    HEADACHE, 2018, 58 : 77 - 77
  • [44] Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn's Disease: results from the global ADMIRE-CD II phase 3 study
    Serclova, Z.
    Garcia-Olmo, D.
    Chen, S. T.
    Wexner, S.
    Panes, J.
    Wu, C.
    Fleshner, P.
    Zhang, B.
    Colombel, J. F.
    Song, M.
    McKay, C.
    Nazarey, P.
    Wright, E.
    Raffals, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I34 - I35
  • [45] EFFICACY AND SAFETY OF ERENUMAB IN EPISODIC MIGRAINE PATIENTS WITH 2-4 PRIOR PREVENTIVE TREATMENT FAILURES: RESULTS FROM THE PHASE 3B LIBERTY STUDY
    Reuter, U.
    Goadsby, P. J.
    Lanteri-Minet, M.
    Ferrari, M. D.
    Wen, S.
    Hours-Zesiger, P.
    Klatt, J.
    CEPHALALGIA, 2018, 38 : 60 - 60
  • [46] EFFICACY AND SAFETY OF DARVADSTROCEL TREATMENT IN PATIENTS WITH COMPLEX PERIANAL FISTULAS AND CROHN'S DISEASE: RESULTS FROM THE GLOBAL ADMIRE-CD II PHASE 3 STUDY
    Serclova, Zuzana
    Garcia-Olmo, Damian
    Chen, Szu-Ta
    Wexner, Steven D.
    Panes, Julian
    Wu, Chunyuan
    Fleshner, Phillip
    Zhang, Barbara
    Colombel, Jean Frederic
    Song, Michael
    McKay, Caroline
    Nazarey, Pradeep
    Wright, Ekaterina
    Raffals, Laura H.
    GASTROENTEROLOGY, 2024, 166 (05) : S181 - S181
  • [47] Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study
    Ochs-Ross, Rachel
    Wajs, Ewa
    Daly, EllaJ.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Drevets, Wayne C.
    Steffens, David C.
    Sanacora, Gerard
    Jamieson, Carol
    Hough, David
    Manji, Husseini
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (05): : 541 - 556
  • [48] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive chronic HBV (CHB): Week 48 efficacy and safety results
    Strasser, S.
    Roberts, S.
    Angus, P.
    Chan, H. L. Y.
    Fung, S.
    Seto, W. K.
    Chuang, W. L.
    Chen, C. Y.
    Kim, H. J.
    Hui, A. J.
    Janssen, H. L. A.
    Chowdhury, A.
    Tsang, T. Y. O.
    Mehta, R.
    Gane, E.
    Flaherty, J. F.
    Massetto, B.
    Kitrinos, K.
    Dinh, P.
    Subramanian, G. M.
    Mchutchison, J. G.
    Lim, Y. S.
    Acharya, S. K.
    Agarwal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 82 - 82
  • [49] Consistent safety and tolerability of Valtoco(R) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study
    Miller, Ian
    Wheless, James W.
    Hogan, Robert E.
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory D.
    Sperling, Michael R.
    Liow, Kore
    Vazquez, Blanca
    Segal, Eric B.
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    EPILEPSIA OPEN, 2021, 6 (03) : 504 - 512
  • [50] EFFICACY AND SAFETY OF NILOTINIB IN OLDER (≥65 YEARS) PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): RESULTS FROM THE PHASE 3 ENESTND (EVALUATING NILOTINIB EFFICACY AND SAFETY IN CLINICAL TRIALS OF NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE CML PATIENTS) STUDY.
    Gorospe, Gerry
    Kantarjian, H. Hagop
    Hochhaus, Andreas
    Larson, Richard
    Saglio, Giuseppe
    Hughes, Timothy
    ONCOLOGY NURSING FORUM, 2012, 39 (03) : E191 - E192